To the articles

USP Reference Standards – Standards of the United States Pharmacopeia
USP reference standards are the global quality benchmark for the analytical validation of pharmaceuticals, biologics, and excipients. Manufacturers of APIs, generics, complex biologics, or pharmaceutical raw materials require comparator substances that regulatory authorities and international pharmacopoeias fully trust.
As an authorized USP specialist retailer, we exclusively deliver standards – with the highest product safety, reliable supply chains and valid results for maximum patient safety.
The range of USP reference standards
Our portfolio includes thousands of USP standards , including:
✔ Drug active ingredient standards (APIs)
✔ Excipient standards
✔ Impurities & Degradation Products
✔ Nitrosamine standards
✔ Pharmaceutical Analytical Impurities (PAI)
✔ Analytical Reference Materials (ARM)
✔ Biologics Standards
✔ Compendial reagents
✔ Dissolution Performance Verification Standards (DPVS)
USP Pharmaceutical Analytical Impurities
READ MOREUSP Biologics
READ MOREUSP Analytical Reference Materials
READ MORE| Order no. | Article name | Batch number | CAS Number | Unit Price € | Quantity |
|---|---|---|---|---|---|
|
USP-1365043
Sale price1.199,50 €
|
Levothyroxine Peak Identification Mixture (3 x 5 mL) (1 mg/mL) (COLD SHIPMENT REQUIRED) |
F114N0 | N/A | 1.199,50 € | |
|
USP-1366080
Sale price939,69 €
|
Lidocaine Related Compound H (50 mg) (2-Chloro-N-(2,6-dimethylphenyl)acetamide) |
R156H0 | 1131-01-7 | 939,69 € | |
|
USP-1366523
Sale price1.115,95 €
|
Linagliptin Related Compound B (15 mg) ((R)-N-(2-Acetylphenyl)-2-[8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl]acetamide) |
F283J0 | 2416949-69-2 | 1.115,95 € | |
|
USP-1366524
Sale price1.115,95 €
|
Linagliptin Related Compound C (15 mg) (7-(But-2-yn-1-yl)-8-[(2-hydroxyethyl)amino]-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione) |
F283K0 | 2074688-84-7 | 1.115,95 € | |
|
USP-1366525
Sale price1.230,41 €
|
Linagliptin Related Compound D (15 mg) ((R,Z)-8-(3-Aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione) |
F283L0 | 1638744-06-5 | 1.230,41 € | |
|
USP-1366526
Sale price1.316,25 €
|
Linagliptin Related Compound E (15 mg) (2-[(R)-3-Aminopiperidine-1-carbonyl]-N-{(R)-1-[7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl]piperidin-3-yl}benzamide) |
F283M0 | 2803370-12-7 | 1.316,25 € | |
|
USP-1366527
Sale price1.139,23 €
|
Linagliptin Related Compound F (15 mg) (8-[(R)-3-Aminopiperidin-1-yl]-7-(buta-1,2-dien-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione) |
F30100 | 2463617-43-6 | 1.139,23 € | |
|
USP-1367515
Sale price1.069,02 €
|
Lindane Related Compound A (25 mg) ((1R,2R,3R,4R,5S,6S)-1,2,3,4,5,6-Hexachlorocyclohexane) |
F055S0 | 319-84-6 | 1.069,02 € | |
|
USP-1367570
Sale price939,69 €
|
Linezolid Related Compound A (20 mg) ((R)-5-(azidomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one) |
R088N0 | 168828-84-0 | 939,69 € |
